(ACC 392) CMK

A cell line, supplied by DSMZ, expressed in Homo sapiens, cited in 9 publications, with 1 published image. Applications used include FC/FACS and IHC.

Go to:

1 image

9 citations

General Information

Supplier

DSMZ

Model Type

Cell line

Species

Homo sapiens (Human)

Cell Line

CMK

Organ

Blood

Disease

Down Syndrome, Myeloid Leukemia Associated with Down Syndrome

View additional product information

Comments

for this reagent

Add your comment here...

Enabling you to share comments privately within your lab, helping to avoid duplicated effort.

Get free early access and help us shape this new feature. Join the private beta

1 image

9 citations

found in the literature

DLK1 is a GATA1s-driven dependency and therapeutic target in Down syndrome-associated myeloid leukemia.

View PDF

In Blood Advances on 23 June 2026 by Verboon, L. J., Barwe, S. P., et al.

Phosphoproteomics identifies determinants of PAK inhibitor sensitivity in leukaemia cells.

View PDF

In Cell Communication and Signaling : CCS on 13 March 2025 by Casado, P., Marfà, S., et al.

Images:

DLK1 is a GATA1s-Driven Dependency and Therapeutic Target in Down Syndrome-Associated Myeloid Leukemia

Preprint on BioRxiv : the Preprint Server for Biology on 3 September 2024 by Verboon, L. J., Barwe, S. P., et al.

Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma.

View Preprint View PDF

In Cell Chemical Biology on 18 August 2022 by Ferguson, I. D., Lin, Y. T., et al.

Targeting the lysine-specific demethylase 1 rewires kinase networks and primes leukemia cells for kinase inhibitor treatment.

View PDF

In Science Signaling on 19 April 2022 by Pedicona, F., Casado, P., et al.

Methylation of dual-specificity phosphatase 4 controls cell differentiation.

In Cell Reports on 27 July 2021 by Su, H., Jiang, M., et al.

Whole-genome sequencing and gene network modules predict gemcitabine/carboplatin-induced myelosuppression in non-small cell lung cancer patients.

View PDF

In NPJ Systems Biology and Applications on 24 August 2020 by Björn, N., Badam, T. V. S., et al.

Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.

In Pediatric Blood Cancer on 1 August 2019 by Wiggers, C. R. M., Govers, A. M. A. P., et al.

AGS67E, an Anti-CD37 Monomethyl Auristatin E Antibody-Drug Conjugate as a Potential Therapeutic for B/T-Cell Malignancies and AML: A New Role for CD37 in AML.

View PDF

In Molecular Cancer Therapeutics on 1 July 2015 by Pereira, D. S., Guevara, C. I., et al.

Is this your product?

Claim your listing to maximise exposure of your products to the hundreds of thousands of researchers that use CiteAb.

Claim my listing

Custom Cell Lines

If you can't find the cell line you're looking for, why not consider a custom reagent from one of these suppliers.

Custom cell line suppliers

Calculators

A collection of useful calculators with more to come!

Use dilution calculator

Report a Problem

Spotted a mistake? Please let us know so that we can put it right!

Report a problem

(ACC 392) CMK

General Information

Additional product information

Supplier also known as

Comments

for this reagent

1 image

9 citations

found in the literature

Is this your product?

Custom Cell Lines

Calculators

Report a Problem

(ACC 392) CMK

General Information

Additional product information

Supplier also known as

Comments for this reagent

1 image 9 citations found in the literature

Is this your product?

Custom Cell Lines

Calculators

Report a Problem

Join thousands of people who already enjoy the CiteAb newsletter

Comments

for this reagent

1 image

9 citations

found in the literature